Motoyoshi, Aya
Nagino, Ken
Sung, Jaemyoung
Midorikawa-Inomata, Akie
Eguchi, Atsuko
Adachi, Takeya
Nakao, Shintaro
Kobayashi, Hiroyuki
Inomata, Takenori
Funding for this research was provided by:
Japan Society for the Promotion of Science (25K20553)
Japan Society for the Promotion of Science (23K16364)
Japan Society for the Promotion of Science (24K19796)
Japan Society for the Promotion of Science (23K18406)
Japan Science and Technology Agency (JPMJFR234I)
Article History
Received: 22 July 2025
Accepted: 9 April 2026
First Online: 21 April 2026
Declarations
:
: K.N. and A.M.I received personal fees from InnoJin, Inc., outside of the submitted work. S.N. reports grants from Kowa Company, Ltd.; Mitsubishi Tanabe Pharma Corporation; Alcon Japan, Ltd.; Santen Pharmaceutical Co., Ltd.; Machida Endoscope Co., Ltd.; Wakamoto Pharmaceutical Co., Ltd.; Bayer Yakuhin, Ltd.; Senju Pharmaceutical Co., Ltd.; Nippon Boehringer Ingelheim Co., Ltd.; Chugai Pharmaceutical Co., Ltd.; Hoya Corporation; and Novartis Pharma K.K. outside the submitted work. T.I. reports non-financial support from Lion Corporation and Sony Network Communications Inc.; grants from Johnson & Johnson Vision Care Inc., Yuimedi Inc., ROHTO Pharmaceutical Co. Ltd., Kobayashi Pharmaceutical Co. Ltd., Kandenko Co. Ltd., and Fukoku Co., Ltd.; and personal fees from Santen Pharmaceutical Co. Ltd., InnoJin Inc., and Ono Pharmaceutical Co. Ltd. outside the submitted work. The remaining authors declare no competing interests.